RFA for Malignant Biliary Obstruction
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Enteral Nutrition After Pancreaticoduodenectomy
- Status
- COMPLETED
- Phase
- NA
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)
- Status
- COMPLETED
- Phase
- PHASE2
ncRNAs in Exosomes of Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)
- Status
- COMPLETED
- Phase
- N/A
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
- Status
- COMPLETED
- Phase
- PHASE2
Liver and Biliary Tumor Tissue Registry
- Status
- TERMINATED
- Phase
- N/A
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle
- Status
- WITHDRAWN
- Phase
- NA
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
- Status
- COMPLETED
- Phase
- N/A